Hemophilia
Hemophilia is the name of several hereditary genetic illnesses that impair the body's ability to control bleeding, an impairment known technically as bleeding diathesis. Genetic deficiencies and a rare autoimmune disorder may cause lowered plasma clotting factor activity so as to compromise blood-clotting; when a blood vessel is injured, a scab does not form and the vessel continues to bleed for an excessive period of time. The bleeding can be external, if the skin is broken by a scrape, cut or abrasion, or it can be internal, into muscles, joints or hollow organs. The result may be visible or subtle.
Though there is no cure for hemophilia, it can be controlled with regular injections of the deficient clotting factor, i.e. factor VIII in hemophilia A or factor IX in hemophilia B. Some hemophiliacs develop antibodies against the replacement factors given to them, so the amount of the factor has to be increased or non-human replacement products must be given, such as porcine factor VIII.
If a patient becomes refractory to replacement coagulation factor as a result of circulating inhibitors, this may be overcome with recombinant human factor VII, which is registered for this indication in many countries.
In western countries, common standards of care fall into one of two categories: prophylaxis or on-demand. Prophylaxis involves the infusion of clotting factor on a regular schedule in order to keep clotting levels sufficiently high to prevent spontaneous bleeding episodes. On-demand treatment involves treating bleeding episodes once they arise.
...More at Wikipedia
Related Links:
Hemophilia
Questions recently asked by other users
Latest Blood / Hematology News From Medical News Today.
- New Biomarkers For Brain Tumor Discovered
- AspenBio Pharma Reports On FDA 510(k) Clinical Trial Progress For AppyScore, World's First Blood-Based Diagnostic Test For Human Appendicitis
- Contaminants In Life-Saving Drug Detected Using Simple New Method
- Burnet Prize Won By Benjamin Kile
- Pernicious Anaemia Awareness Week - "Needless Suffering Must Stop"
- Researchers Tackle CLL, Diabetes And Trauma-Hemorrhage - Molecular Medicine, A Bi-Monthly Journal
- Novel Oral Anticoagulant, ATI-5923, Promises Potential Benefits Over Leading Treatment
- Ferumoxytol Resubmission Designated Complete, Class 1 Response By FDA - Iron Deficiency Anemia In Chronic Kidney Disease Patients
- Enrollment In EMERALD 1 Complete, 3rd Of 4 Phase 3 Clinical Trials Of Hematide™ To Treat Anemia In Chronic Renal Failure Patients
- Case Of Patient "Cured" Of HIV Baffles Doctors
- Bone Marrow Toxicity In Advanced Lung Cancer May Be Reduced By Proton Therapy And Concurrent Chemotherapy
